Oxaliplatin accumulation in cancer associated fibroblasts is associated with colorectal cancer progression and resistance to therapy. nature.com/articles/s4146… Alexandre Calon @calonlab Jenniffer Linares @IMIM_research Hospital del Mar INCLIVA Vall d’Hebron Institute of Oncology (VHIO) IRB Barcelona #CancerResearch

🔝 Just out our paper published in ACS Publications led by Alexandre Calon & Daniele Lo Re at @IMIM_research CalonLab and IRB Barcelona ! 📌 Can we reduce #chemo resistance in #CRC ? Don’t miss reading the full story 👇🏼 pubs.acs.org/doi/10.1021/ac… nature.com/articles/s4146…

El càncer de colon és el més freqüent entre homes i dones. L'hospital del Mar descobreix per què alguns pacients són resistents a la quimioteràpia | Elena Santos RTVE Catalunya Hospital del Mar ➕ Notícies a rtve.cat

Cáncer de pulmón: Opinión positiva Keytruda en primera línea en Europa sco.lt/6aSazR

NewLink Genetics | IDO immune pathway inhibitors sco.lt/7rBG2z

Some stats for treatment vs detection in improving life expectancy in #cancer patients :#ValueOfMeds Surprised?

People are talking about how #immunotherapy is transforming #cancer care. What they’re saying: onphr.ma/2hAR4lk

Nuestro objetivo es potenciar la capacidad del sistema inmunitario para luchar contra el #cáncer bit.ly/1UjfvMx

Nurse practitioners make history with the first FAA-approved #drone delivered medications: clinicaladvisor.com/practice-manag… via Clinical Advisor

Invivo synthesis of Anticancer drugs: Nature : Nature Research sco.lt/5OGLYX

Sanofi/Regeneron hit with FDA delay for sarilumab | FierceBiotech sco.lt/6lB6jx

Biomarkers Predict Rituximab Response in RA sco.lt/8bmNST

El problema de los precios de farmacéuticas en EEUU se agravará en 2017. pmfarma.es/noticias/23768…

La incertidumbre económica dictará sentencia entre los líderes de la industria farmacéutica en 2017... | Scoop.it sco.lt/7Hdyk5

Cheryl Clark Thanks for the retweet(s)! My goal with the etsy shop is to be able to make donations to Arthritis National Research Foundation <3 thanks for sharing!

Sanofi and Regeneron's would-be blockbuster tops Humira in arthritis | FierceBiotech | Scoop.it sco.lt/8OzQrx

Sanofi's sarilumab bests blockbuster Humira in Phase 3 study | Scoop.it sco.lt/7KRnqj

Nanodiscs Train Immune System to Attack and Kill Tumors | | Scoop.it sco.lt/6vnk8X

I/O: The Strategic Supernova In Cancer Today | LifeSciVC | Scoop.it sco.lt/5w2lpB

Una #app de reconocimiento facial para diagnosticar #EnfermedadesRaras bit.ly/2tbc9Fa